| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.0075 | 0.8 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.9 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.014 | 0.9 |